gregory merk  nordson corporation  zoominfocom merckcom  products  home worldwide  contact us contact us faq navigation about us × about us about us corporate responsibility reimbursement support and patient assistance programs leadership – board of directors – executive committee our work our work in antimicrobial resistance our work in hepatitis c our work in diabetes our work in oncology our work in hiv our work in vaccines how we operate – code of conduct our values and standards our values and standards for external business partners – compliance – privacy – transparency and privacy – internet privacy policy – cookie privacy commitment – cross border policy – employment privacy  data protection – diversity – employee diversity – supplier diversity programs and partnerships what we buy definitions register potential supplier supplier diversity views and positions – access and affordability – access to investigational medicines – innovation – quality and safety – sales and marketing – responsible public policy and advocacy public policy position statements trade association memberships our history company fact sheet our people featured stories our legacy  and future  in american manufacturing mercks it organization expands into austin texas mectizan donation is one for the record books journey for control a point of view by dr bao lam fighting some of the worlds toughest bacterial infections meet dan cua it takes a village type  diabetes a focus on ac may is for mothers pushing to outpace superbugs merck announces enhancements to family leave time classical hodgkin lymphoma facing cancer in young adulthood world sleep day bekindalwaysnoah the merckregenstrief collaboration why drug discovery is the foundation of merck’s future how chronic hepatitis c is impacting our veterans meet gokul swaminathan merck honors research microbiologist h boyd woodruff phd merck uses amazon web services to develop voiceenabled solutions cancer needs cures still merck be well challenge  — bringing the outside in a point of view by adam schechter president of global human health at merck your cancer game plan merck foundation grant helps expand project echo merck’s commitment to prevention and care for ncds meet jay schiller merck research laboratories expands into south san francisco test talk take action bridging the gap in diabetes care world diabetes day  meet harriet johnson merck employees surpass goal of  volunteer hours merck for mothers  pep talk meet commander adam scott meet noreen rizvi ebola outbreak a point of view by dr roger dansey a point of view by dr gregory lubiniecki merck’s susan shiff selected faces of the future merck research laboratories honored living with breast cancer health literacy a point of view by julie gerberding md mph meet paige cramer merck releases  corporate responsibility report how merck animal health helped to curb a new strain of civ women in science  merck fellowship for global health meet daria hazuda a point of view by dr jonathan cheng understanding head and neck cancer hpv awareness meet arnaub chatterjee fasting and diabetes understanding diabetes living with type  diabetes its personal series collaborating to cure meet mike thien roy vagelos honored by american heart association changing the statistics charting a new course in cancer care new approaches to fighting cancer melanoma never walk alone be safe in the sun americas diabetes challenge world immunization week merck for mothers at the women in the world summit vaccines our history our legacy the impact of cancer merck’s commitment to hepatitis c hepatitis c a silent disease and growing concern using water wisely meet george w merck heart disease guided by research inspired by hope why animal health matters merck turns  cervical health awareness month rallying to meet the need william campbell wins nobel prize meet christopher kistler diversity and inclusion good for business understanding alzheimer’s disease living with hiv meet jason cheung hepatitis c a medical — and social — diagnosis the fight against hepatitis c saluting those who serve lung cancer challenges and reasons for hope real innovation world diabetes day lung cancer refugee and migrant relief efforts what is c difficile beyond tired so are they meet alexander buitrago santanilla ken frazier receives lifetime achievement award merck employees walk to end alzheimer’s ken frazier at the clinton global initiative helping to advance a new set of un global goals merck fellowship for global health  corporate responsibility report new therapies to attack infections the race against resistance identifying the next generation of antibacterial therapies the fight against antimicrobial resistance mectizan donation program meet paul reichert merck for mothers at tedwomen meet spencer dreher merck and hivaids fasting and diabetes mercks rule the real talk campaign meet daisy richardson art for all msd in japan bringing back the beach a commitment to diabetes research a silent disease and growing concern meet tim cernak melanoma  never walk alone be safe in the sun may is for mothers bone health awareness americas diabetes challenge pushing to outpace superbugs the evolution of cancer research parasites and your pets meet ayesha sitlani every woman every child event everyday heroes new approaches to fighting cancer insomnia advancing oncology research through clinical trials bridging the gap in diabetes care closing the circle on rabies desafiando la diabetes understanding diabetes helping empower women living with hiv diabetes and travel vaccines our history our legacy the impact of cancer a point of view by eric rubin md making a difference inventing for life × inventing for life inventing for life products × products products product list az vaccines  prescribing information prescription products  prescribing information oncology products  prescribing information animal health product patents authorized distributors vaccine contracted distributors research × research research our people our culture – the mrl postdoctoral research fellow program our rd process what were working on pipeline clinical trials invent with us discover where our research happens licensing × licensing business development  licensing incyte moderna ngm biopharmaceuticals bdl contacts news  events newsroom × newsroom newsroom news releases – prescription medicine news – consumer care news – vaccine news – research  development news – corporate news – financial news – corporate responsibility news – animal health news information centers – diabetes – ebola – hepatitis c – oncology company statements media center company snapshot social media careers × careers careers apply now what’s possible my career journey merck anna dickstein my career journey merck fran murphy my career journey merck paige cramer why merck – diversity at merck – from service to science – prepared for launch – compensation and benefits how will you invent the future my career journey merck frank clyburn canada msd worldwide investors × investors investors product pipeline news events  presentations stock info – stock quote  chart – historical price lookup – investment calculator – dividend history – stock splits – analyst coverage financials – quarterly reports – annual reports  proxy – sec filings governance investor resources – faqs – stockholder services – corporate responsibility – information request – sign up for email alerts – other – contact us menu menu product list a – z with a steady focus on innovation and sound science we work to deliver vaccines medications and animal health products that can help millions around the world the product websites presented here are intended for use in the united states its territories and puerto rico only other countries may have different regulatory requirements and review practices that may require referencing different information if you are a resident of a country other than the united states please select worldwide at the top of the page to find information about our offices around the globe explore our product portfolio a b c d e f g h i j k l m n o p q r s t u v w x y z a antivenin™ latrodectus mactans prescription prescribing information asmanex® hfa mometasone furoate inhalation aerosol for oral inhalation use prescription prescribing information patient product information asmanex® twisthaler® mometasone furoate inhalation powder prescription prescribing information patient product information product website avelox® moxifloxacin hydrochloride tablets filmcoated prescription prescribing information medication guide avelox® iv moxifloxacin hydrochloride injection solution for iv use prescription prescribing information medication guide top b bcg vaccine   for percutaneous use prescribing information instructions for use belsomra® suvorexant tablets for oral use civ prescribing information medication guide product website bridion® sugammadex injection for intravenous use prescribing information top c cancidas® caspofungin acetate for injection for intravenous use prescription prescribing information celestone® soluspan® betamethasone sodium phosphate and betamethasone acetate   injectable suspension usp  mg ml  mgml prescribing information clarinex® desloratadine tablets and oral solution for oral use prescription prescribing information patient product information clarinexd®  hour extended release tablets   desloratadinepseudoephedrine sulfate for oral use prescription prescribing information patient product information cozaar® losartan potassium tablets prescription prescribing information patient product information crixivan® indinavir sulfate capsules prescription prescribing information patient product information cubicin® daptomycin for injection for intravenous use prescription prescribing information cubicin® rf daptomycin for injection for intravenous use prescription prescribing information cushion grip® consumer product website cyclessa® tablets desogestrel and ethinyl estradiol usp tablets prescribing information patient package insert patient package insert brief summary top d desogen® tablets   desogestrel and ethinyl estradiol tablets usp consumer prescribing information patient package insert patient package insert brief summary dificid® fidaxomicin tablets for oral use prescription prescribing information diprolene® af   augmented betamethasone dipropionate cream  for topical use consumer prescribing information diprolene®    augmented betamethasone dipropionate lotion  for topical use consumer prescribing information diprolene®    augmented betamethasone dipropionate ointment  for topical use consumer prescribing information dulera® mometasone furoate and formoterol fumarate dihydrate inhalation aerosol for oral inhalation use consumer prescribing information medication guide product website top e elocon® mometasone furoate cream  for topical use consumer prescribing information elocon® mometasone furoate lotion  for topical use consumer prescribing information elocon® mometasone furoate ointment  for topical use consumer prescribing information emend® aprepitant capsules aprepitant for oral suspension prescription prescribing information patient product information instructions for use product website emend®    fosaprepitant dimeglumine for injection for intravenous use prescription prescribing information  mg edta formulation prescribing information  mg edta formulation patient product information entereg® alvimopan capsules for oral use prescription prescribing information top f follistim® aq cartridge follitropin beta injection for subcutaneous use prescribing information patient product information and instructions for use follistim® aq follitropin beta injection for subcutaneous use or intramuscular use prescribing information patient product information and instructions for use foradil® aerolizer® formoterol fumarate inhalation powder prescription prescribing information medication guide fosamax® alendronate sodium tablets and oral solution prescribing information medication guide fosamax® plus d alendronate sodiumcholecalciferol tablets prescription prescribing information medication guide top g ganirelix acetate injection prescription prescribing information gardasil® human papillomavirus quadrivalent types    and  vaccine recombinant vaccine prescribing information patient product information product website gardasil® human papillomavirus valent vaccine recombinant suspension for intramuscular   injection vaccine prescribing information patient product information grastek® timothy grass pollen allergen extract tablet for sublingual use prescription prescribing information medication guide product website guanidine hydrochloride tablets prescription prescribing information top h hyzaar® losartan potassium and hydrochlorothiazide tablets prescription prescribing information patient product information top i implanon® etonogestrel implant for subdermal use prescription prescribing information patient product information patient consent form product website integrilin® eptifibatide injection prescription prescribing information intron® a interferon alfab recombinant for injection prescription prescribing information  ml diluent medication guide instructions for use – powder for solution  ml diluent instructions for use – solution for injection product website invanz® ertapenem for injection prescription prescribing information product website isentress® raltegravir filmcoated tablets for oral use   isentress® hd raltegravir filmcoated tablets for oral use   isentress® raltegravir chewable tablets for oral use   isentress® raltegravir for oral suspension prescription prescribing information patient product information instructions for use product website top j janumet® sitagliptin and metformin hcl tablets prescription prescribing information medication guide product website janumet® xr sitagliptin and metformin hcl extendedrelease tablets prescribing information medication guide product website januvia® sitagliptin tablets prescription prescribing information medication guide product website top k keytruda® pembrolizumab for injection for intravenous use    keytruda® pembrolizumab injection for intravenous use prescribing information medication guide product website top l lotrisone® cream   clotrimazole and betamethasone dipropionate consumer prescribing information patient product information top m maxalt® rizatriptan benzoate tablets for oral use    maxaltmlt® rizatriptan benzoate orally disintegrating tablets prescription prescribing information patient product information mmr® ii measles mumps and rubella virus vaccine live vaccine prescribing information patient product information top n nasonex® mometasone furoate monohydrate nasal spray  mcg†   †calculated on the anhydrous basis prescription prescribing information patient product information product website nexplanon® etonogestrel implant radiopaque subdermal use only prescribing information patient product information patient consent form nitrodur®    nitroglycerin transdermal infusion system prescribing information patient product information noxafil® posaconazole injection for intravenous use   delayedrelease tablets for oral use and oral suspension prescription prescribing information patient product information nuvaring® etonogestrelethinyl estradiol vaginal ring prescription prescribing information patient product information instructions for use product website top o top p liquid pedvax hib® haemophilus b conjugate vaccine meningococcal protein conjugate vaccine prescribing information pegintron® peginterferon alfab injection for subcutaneous use prescription prescribing information  ml diluent prescribing information  ml diluent medication guide instructions for use – powder for injection traditional vial and syringe   ml diluent instructions for use – powder for injection traditional vial and syringe   ml diluent instructions for use – pegintron redipen® pneumovax®  pneumococcal vaccine polyvalent sterile liquid vaccine for intramuscular or   subcutaneous injection vaccine prescribing information patient product information product website pregnyl® chorionic gonadotropin for injection usp prescription prescribing information primaxin® iv imipenem and cilastatin for injection prescription prescribing information instructions for use prinivil® lisinopril tablets prescription prescribing information propecia® finasteride tablets for oral use prescription prescribing information patient product information proquad® measles mumps rubella and varicella virus vaccine live   lyophilized preparation for subcutaneous injection vaccine prescribing information ndc  vaccine prescribing information ndc  proscar® finasteride tablets prescription prescribing information patient product information proventil® hfa albuterol sulfate inhalation aerosol prescription prescribing information patient product information product website top r ragwitek® short ragweed pollen allergen extract tablet for sublingual use prescription prescribing information medication guide product website rebetol® ribavirin usp capsules and oral solution prescription prescribing information medication guide recombivax hb® hepatitis b vaccine recombinant vaccine prescribing information remeron® mirtazapine tablets prescription prescribing information medication guide remeronsoltab® mirtazapine orally disintegrating tablets prescription prescribing information medication guide renflexis™ infliximababda for injection for intravenous use prescription prescribing information medication guide rotateq® rotavirus vaccine live oral pentavalent oral solution vaccine prescribing information patient product information top s sinemet® carbidopalevodopa tablets prescription prescribing information sinemet® cr carbidopalevodopa sustainedrelease tablets prescription prescribing information singulair® montelukast sodium tablets chewable tablets and oral granules prescription prescribing information patient product information sivextro® tedizolid phosphate for injection for intravenous use   sivextro® tedizolid phosphate tablet for oral use prescription prescribing information stromectol® ivermectin tablets prescription prescribing information sylatron™ peginterferon alfab for injection for subcutaneous use prescription prescribing information  ml diluent medication guide instructions for use  ml diluent top t temodar® temozolomide capsules prescription prescribing information patient product information pharmacist information temodar® temozolomide for injection prescription prescribing information patient product information pharmacist information tice® bcg bcg live for intravesical use prescription prescribing information trusopt® dorzolamide hydrochloride ophthalmic solution sterile ophthalmic solution  prescription prescribing information instructions for use top v vaqta® hepatitis a vaccine inactivated vaccine prescribing information varivax® varicella virus vaccine live vaccine prescribing information patient product information victrelis® boceprevir capsules for oral use vaccine prescribing information medication guide vytorin® ezetimibe and simvastatin tablets prescription prescribing information patient product information product website top z zemuron® rocuronium bromide injection solution for intravenous use prescription prescribing information zepatier® elbasvir and grazoprevir tablets for oral use prescription prescribing information patient product information product website zerbaxa™ ceftolozane and tazobactam for injection for intravenous use prescription prescribing information zetia® ezetimibe tablets prescription prescribing information patient product information product website zinplava™ bezlotoxumab injection for intravenous use prescription prescribing information patient product information zocor®  simvastatin tablets prescription prescribing information zolinza® vorinostat capsules prescription prescribing information patient product information zontivity® vorapaxar tablets  mg for oral use equivalent to  mg vorapaxar sulfate prescription prescribing information medication guide zostavax® zoster vaccine live suspension for subcutaneous injection vaccine prescribing information patient product information product website top trademarks appearing on this website are owned licensed to promoted or distributed by merck its subsidiaries or affiliates except as noted healthcare professionals offers direct access to our professional resources healthcare professionals website report adverse experience to report an adverse experience with a specific merck product please call the merck national service center at  related information patient assistance program direct to consumer advertising policy copyright   merck sharp  dohme corp a subsidiary of merck  co inc all rights reserved forwardlooking statement privacy terms of use site map ×close forwardlooking statement forwardlooking statement of merck  co inc kenilworth nj usa this website of merck  co inc kenilworth nj usa the “company” includes “forwardlooking statements” within the meaning of the safe harbor provisions of the united states private securities litigation reform act of  these statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties there can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful if underlying assumptions prove inaccurate or risks or uncertainties materialize actual results may differ materially from those set forth in the forwardlooking statements risks and uncertainties include but are not limited to general industry conditions and competition general economic factors including interest rate and currency exchange rate fluctuations the impact of pharmaceutical industry regulation and healthcare legislation in the united states and internationally global trends toward healthcare cost containment technological advances new products and patents attained by competitors challenges inherent in new product development including obtaining regulatory approval the company’s ability to accurately predict future market conditions manufacturing difficulties or delays financial instability of international economies and sovereign risk dependence on the effectiveness of the company’s patents and other protections for innovative products and the exposure to litigation including patent litigation andor regulatory actions the company undertakes no obligation to publicly update any forwardlooking statement whether as a result of new information future events or otherwise additional factors that could cause results to differ materially from those described in the forwardlooking statements can be found in the company’s  annual report on form k and the company’s other filings with the securities and exchange commission sec available at the sec’s internet site wwwsecgov no duty to update the information contained in this website was current as of the date presented the company assumes no duty to update the information to reflect subsequent developments consequently the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date x worldwide merck canada united states msd merck is known as msd outside the united states and canada clicking on any of the links below will take you to a website intended for those living outside the united states and canada algeria – french argentina – spanish australia – english austria – german belgium – dutch french english brazil – portuguese bulgaria – bulgarian caribbean – english central america – spanish chile – spanish china – simplified chinese colombia – spanish costa rica – spanish croatia – croatian czech republic – czech denmark – danish dominican republic – dominican ecuador – spanish egypt – english estonia – estonian finland – finnish france – french fulford india – english germany – german greece – greek hong kong – chinese english hungary – hungarian india – english indonesia – english ireland – english italy – italian japan – japanese latvia – latvian lithuania – lithuanian malaysia – english mexico – spanish montenegro – serbian netherlands – dutch new zealand – english norway – norwegian peru – spanish philippines – english poland – polish portugal – portuguese puerto rico – spanish english romania – romanian english russia – russian saudi arabia – english serbia – serbian singapore – english slovakia – slovak slovenia – slovene south africa – english south korea – korean spain – spanish sweden – swedish switzerland – english french german taiwan – traditional chinese thailand – thai english turkey – turkish ukraine – ukrainian united kingdom – english venezuela – spanish vietnam – vietnamese close merckcom  products  vaccines worldwide  contact us contact us faq navigation about us × about us about us corporate responsibility reimbursement support and patient assistance programs leadership – board of directors – executive committee our work our work in antimicrobial resistance our work in hepatitis c our work in diabetes our work in oncology our work in hiv our work in vaccines how we operate – code of conduct our values and standards our values and standards for external business partners – compliance – privacy – transparency and privacy – internet privacy policy – cookie privacy commitment – cross border policy – employment privacy  data protection – diversity – employee diversity – supplier diversity programs and partnerships what we buy definitions register potential supplier supplier diversity views and positions – access and affordability – access to investigational medicines – innovation – quality and safety – sales and marketing – responsible public policy and advocacy public policy position statements trade association memberships our history company fact sheet our people featured stories our legacy  and future  in american manufacturing mercks it organization expands into austin texas mectizan donation is one for the record books journey for control a point of view by dr bao lam fighting some of the worlds toughest bacterial infections meet dan cua it takes a village type  diabetes a focus on ac may is for mothers pushing to outpace superbugs merck announces enhancements to family leave time classical hodgkin lymphoma facing cancer in young adulthood world sleep day bekindalwaysnoah the merckregenstrief collaboration why drug discovery is the foundation of merck’s future how chronic hepatitis c is impacting our veterans meet gokul swaminathan merck honors research microbiologist h boyd woodruff phd merck uses amazon web services to develop voiceenabled solutions cancer needs cures still merck be well challenge  — bringing the outside in a point of view by adam schechter president of global human health at merck your cancer game plan merck foundation grant helps expand project echo merck’s commitment to prevention and care for ncds meet jay schiller merck research laboratories expands into south san francisco test talk take action bridging the gap in diabetes care world diabetes day  meet harriet johnson merck employees surpass goal of  volunteer hours merck for mothers  pep talk meet commander adam scott meet noreen rizvi ebola outbreak a point of view by dr roger dansey a point of view by dr gregory lubiniecki merck’s susan shiff selected faces of the future merck research laboratories honored living with breast cancer health literacy a point of view by julie gerberding md mph meet paige cramer merck releases  corporate responsibility report how merck animal health helped to curb a new strain of civ women in science  merck fellowship for global health meet daria hazuda a point of view by dr jonathan cheng understanding head and neck cancer hpv awareness meet arnaub chatterjee fasting and diabetes understanding diabetes living with type  diabetes its personal series collaborating to cure meet mike thien roy vagelos honored by american heart association changing the statistics charting a new course in cancer care new approaches to fighting cancer melanoma never walk alone be safe in the sun americas diabetes challenge world immunization week merck for mothers at the women in the world summit vaccines our history our legacy the impact of cancer merck’s commitment to hepatitis c hepatitis c a silent disease and growing concern using water wisely meet george w merck heart disease guided by research inspired by hope why animal health matters merck turns  cervical health awareness month rallying to meet the need william campbell wins nobel prize meet christopher kistler diversity and inclusion good for business understanding alzheimer’s disease living with hiv meet jason cheung hepatitis c a medical — and social — diagnosis the fight against hepatitis c saluting those who serve lung cancer challenges and reasons for hope real innovation world diabetes day lung cancer refugee and migrant relief efforts what is c difficile beyond tired so are they meet alexander buitrago santanilla ken frazier receives lifetime achievement award merck employees walk to end alzheimer’s ken frazier at the clinton global initiative helping to advance a new set of un global goals merck fellowship for global health  corporate responsibility report new therapies to attack infections the race against resistance identifying the next generation of antibacterial therapies the fight against antimicrobial resistance mectizan donation program meet paul reichert merck for mothers at tedwomen meet spencer dreher merck and hivaids fasting and diabetes mercks rule the real talk campaign meet daisy richardson art for all msd in japan bringing back the beach a commitment to diabetes research a silent disease and growing concern meet tim cernak melanoma  never walk alone be safe in the sun may is for mothers bone health awareness americas diabetes challenge pushing to outpace superbugs the evolution of cancer research parasites and your pets meet ayesha sitlani every woman every child event everyday heroes new approaches to fighting cancer insomnia advancing oncology research through clinical trials bridging the gap in diabetes care closing the circle on rabies desafiando la diabetes understanding diabetes helping empower women living with hiv diabetes and travel vaccines our history our legacy the impact of cancer a point of view by eric rubin md making a difference inventing for life × inventing for life inventing for life products × products products product list az vaccines  prescribing information prescription products  prescribing information oncology products  prescribing information animal health product patents authorized distributors vaccine contracted distributors research × research research our people our culture – the mrl postdoctoral research fellow program our rd process what were working on pipeline clinical trials invent with us discover where our research happens licensing × licensing business development  licensing incyte moderna ngm biopharmaceuticals bdl contacts news  events newsroom × newsroom newsroom news releases – prescription medicine news – consumer care news – vaccine news – research  development news – corporate news – financial news – corporate responsibility news – animal health news information centers – diabetes – ebola – hepatitis c – oncology company statements media center company snapshot social media careers × careers careers apply now what’s possible my career journey merck anna dickstein my career journey merck fran murphy my career journey merck paige cramer why merck – diversity at merck – from service to science – prepared for launch – compensation and benefits how will you invent the future my career journey merck frank clyburn canada msd worldwide investors × investors investors product pipeline news events  presentations stock info – stock quote  chart – historical price lookup – investment calculator – dividend history – stock splits – analyst coverage financials – quarterly reports – annual reports  proxy – sec filings governance investor resources – faqs – stockholder services – corporate responsibility – information request – sign up for email alerts – other – contact us menu menu vaccines  prescribing information vaccines are one of the greatest public health success stories in history and merck has played its part in that story merck and its legacy companies have been working to discover and develop vaccines for more than a century our unique vaccines have helped prevent a number of diseases including ones never thought preventable today we remain dedicated to the complex business of researching and producing vaccines bcg vaccinefor percutaneous use prescribing information instructions for use gardasil® human papillomavirus quadrivalent types    and  vaccine recombinant prescribing information patient product information product website gardasil® human papillomavirus valent vaccine recombinant suspension for intramuscular injection prescribing information patient product information mmr® ii measles mumps and rubella virus vaccine live prescribing information patient product information pedvax hib® haemophilus b conjugate vaccine meningococcal protein conjugate prescribing information pneumovax®  pneumococcal vaccine polyvalent sterile liquid vaccine for intramuscular or subcutaneous injection prescribing information patient product information product website proquad® measles mumps rubella and varicella virus vaccine livelyophilized preparation for subcutaneous injection prescribing information ndc  prescribing information ndc  recombivax hb® hepatitis b vaccine recombinant prescribing information rotateq® rotavirus vaccine live oral pentavalent oral solution prescribing information patient product information vaqta® hepatitis a vaccine inactivated suspension for intramuscular injection prescribing information varivax® varicella virus vaccine live prescribing information patient product information zostavax® zoster vaccine live suspension for subcutaneous injection prescribing information patient product information product website   trademarks appearing on this website are owned licensed to promoted or distributed by merck its subsidiaries or affiliates except as noted for more information vaccine contracted distributors learn more report adverse experience to report an adverse experience with a specific merck product please call the merck national service center at  copyright   merck sharp  dohme corp a subsidiary of merck  co inc all rights reserved forwardlooking statement privacy terms of use site map ×close forwardlooking statement forwardlooking statement of merck  co inc kenilworth nj usa this website of merck  co inc kenilworth nj usa the “company” includes “forwardlooking statements” within the meaning of the safe harbor provisions of the united states private securities litigation reform act of  these statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties there can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful if underlying assumptions prove inaccurate or risks or uncertainties materialize actual results may differ materially from those set forth in the forwardlooking statements risks and uncertainties include but are not limited to general industry conditions and competition general economic factors including interest rate and currency exchange rate fluctuations the impact of pharmaceutical industry regulation and healthcare legislation in the united states and internationally global trends toward healthcare cost containment technological advances new products and patents attained by competitors challenges inherent in new product development including obtaining regulatory approval the company’s ability to accurately predict future market conditions manufacturing difficulties or delays financial instability of international economies and sovereign risk dependence on the effectiveness of the company’s patents and other protections for innovative products and the exposure to litigation including patent litigation andor regulatory actions the company undertakes no obligation to publicly update any forwardlooking statement whether as a result of new information future events or otherwise additional factors that could cause results to differ materially from those described in the forwardlooking statements can be found in the company’s  annual report on form k and the company’s other filings with the securities and exchange commission sec available at the sec’s internet site wwwsecgov no duty to update the information contained in this website was current as of the date presented the company assumes no duty to update the information to reflect subsequent developments consequently the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date x worldwide merck canada united states msd merck is known as msd outside the united states and canada clicking on any of the links below will take you to a website intended for those living outside the united states and canada algeria – french argentina – spanish australia – english austria – german belgium – dutch french english brazil – portuguese bulgaria – bulgarian caribbean – english central america – spanish chile – spanish china – simplified chinese colombia – spanish costa rica – spanish croatia – croatian czech republic – czech denmark – danish dominican republic – dominican ecuador – spanish egypt – english estonia – estonian finland – finnish france – french fulford india – english germany – german greece – greek hong kong – chinese english hungary – hungarian india – english indonesia – english ireland – english italy – italian japan – japanese latvia – latvian lithuania – lithuanian malaysia – english mexico – spanish montenegro – serbian netherlands – dutch new zealand – english norway – norwegian peru – spanish philippines – english poland – polish portugal – portuguese puerto rico – spanish english romania – romanian english russia – russian saudi arabia – english serbia – serbian singapore – english slovakia – slovak slovenia – slovene south africa – english south korea – korean spain – spanish sweden – swedish switzerland – english french german taiwan – traditional chinese thailand – thai english turkey – turkish ukraine – ukrainian united kingdom – english venezuela – spanish vietnam – vietnamese close merckcom  products  oncology worldwide  contact us contact us faq navigation about us × about us about us corporate responsibility reimbursement support and patient assistance programs leadership – board of directors – executive committee our work our work in antimicrobial resistance our work in hepatitis c our work in diabetes our work in oncology our work in hiv our work in vaccines how we operate – code of conduct our values and standards our values and standards for external business partners – compliance – privacy – transparency and privacy – internet privacy policy – cookie privacy commitment – cross border policy – employment privacy  data protection – diversity – employee diversity – supplier diversity programs and partnerships what we buy definitions register potential supplier supplier diversity views and positions – access and affordability – access to investigational medicines – innovation – quality and safety – sales and marketing – responsible public policy and advocacy public policy position statements trade association memberships our history company fact sheet our people featured stories our legacy  and future  in american manufacturing mercks it organization expands into austin texas mectizan donation is one for the record books journey for control a point of view by dr bao lam fighting some of the worlds toughest bacterial infections meet dan cua it takes a village type  diabetes a focus on ac may is for mothers pushing to outpace superbugs merck announces enhancements to family leave time classical hodgkin lymphoma facing cancer in young adulthood world sleep day bekindalwaysnoah the merckregenstrief collaboration why drug discovery is the foundation of merck’s future how chronic hepatitis c is impacting our veterans meet gokul swaminathan merck honors research microbiologist h boyd woodruff phd merck uses amazon web services to develop voiceenabled solutions cancer needs cures still merck be well challenge  — bringing the outside in a point of view by adam schechter president of global human health at merck your cancer game plan merck foundation grant helps expand project echo merck’s commitment to prevention and care for ncds meet jay schiller merck research laboratories expands into south san francisco test talk take action bridging the gap in diabetes care world diabetes day  meet harriet johnson merck employees surpass goal of  volunteer hours merck for mothers  pep talk meet commander adam scott meet noreen rizvi ebola outbreak a point of view by dr roger dansey a point of view by dr gregory lubiniecki merck’s susan shiff selected faces of the future merck research laboratories honored living with breast cancer health literacy a point of view by julie gerberding md mph meet paige cramer merck releases  corporate responsibility report how merck animal health helped to curb a new strain of civ women in science  merck fellowship for global health meet daria hazuda a point of view by dr jonathan cheng understanding head and neck cancer hpv awareness meet arnaub chatterjee fasting and diabetes understanding diabetes living with type  diabetes its personal series collaborating to cure meet mike thien roy vagelos honored by american heart association changing the statistics charting a new course in cancer care new approaches to fighting cancer melanoma never walk alone be safe in the sun americas diabetes challenge world immunization week merck for mothers at the women in the world summit vaccines our history our legacy the impact of cancer merck’s commitment to hepatitis c hepatitis c a silent disease and growing concern using water wisely meet george w merck heart disease guided by research inspired by hope why animal health matters merck turns  cervical health awareness month rallying to meet the need william campbell wins nobel prize meet christopher kistler diversity and inclusion good for business understanding alzheimer’s disease living with hiv meet jason cheung hepatitis c a medical — and social — diagnosis the fight against hepatitis c saluting those who serve lung cancer challenges and reasons for hope real innovation world diabetes day lung cancer refugee and migrant relief efforts what is c difficile beyond tired so are they meet alexander buitrago santanilla ken frazier receives lifetime achievement award merck employees walk to end alzheimer’s ken frazier at the clinton global initiative helping to advance a new set of un global goals merck fellowship for global health  corporate responsibility report new therapies to attack infections the race against resistance identifying the next generation of antibacterial therapies the fight against antimicrobial resistance mectizan donation program meet paul reichert merck for mothers at tedwomen meet spencer dreher merck and hivaids fasting and diabetes mercks rule the real talk campaign meet daisy richardson art for all msd in japan bringing back the beach a commitment to diabetes research a silent disease and growing concern meet tim cernak melanoma  never walk alone be safe in the sun may is for mothers bone health awareness americas diabetes challenge pushing to outpace superbugs the evolution of cancer research parasites and your pets meet ayesha sitlani every woman every child event everyday heroes new approaches to fighting cancer insomnia advancing oncology research through clinical trials bridging the gap in diabetes care closing the circle on rabies desafiando la diabetes understanding diabetes helping empower women living with hiv diabetes and travel vaccines our history our legacy the impact of cancer a point of view by eric rubin md making a difference inventing for life × inventing for life inventing for life products × products products product list az vaccines  prescribing information prescription products  prescribing information oncology products  prescribing information animal health product patents authorized distributors vaccine contracted distributors research × research research our people our culture – the mrl postdoctoral research fellow program our rd process what were working on pipeline clinical trials invent with us discover where our research happens licensing × licensing business development  licensing incyte moderna ngm biopharmaceuticals bdl contacts news  events newsroom × newsroom newsroom news releases – prescription medicine news – consumer care news – vaccine news – research  development news – corporate news – financial news – corporate responsibility news – animal health news information centers – diabetes – ebola – hepatitis c – oncology company statements media center company snapshot social media careers × careers careers apply now what’s possible my career journey merck anna dickstein my career journey merck fran murphy my career journey merck paige cramer why merck – diversity at merck – from service to science – prepared for launch – compensation and benefits how will you invent the future my career journey merck frank clyburn canada msd worldwide investors × investors investors product pipeline news events  presentations stock info – stock quote  chart – historical price lookup – investment calculator – dividend history – stock splits – analyst coverage financials – quarterly reports – annual reports  proxy – sec filings governance investor resources – faqs – stockholder services – corporate responsibility – information request – sign up for email alerts – other – contact us menu menu oncology products  prescribing information cancer is one of the worlds most urgent unmet medical needs helping people fight cancer is our passion we are committed to developing breakthrough biomedical innovations to help extend and improve the lives of people with cancer worldwide emend® aprepitant capsules aprepitant for oral suspension prescribing information patient product information instructions for use product website emend® fosaprepitant dimeglumine for injection for intravenous use prescribing information  mg edta formulation prescribing information  mg edta formulation patient product information intron® a interferon alfab recombinant for injection prescribing information  ml diluent medication guide instructions for use  powder for solution  ml diluent instructions for use – solution for injection product website keytruda® pembrolizumab for injection for intravenous use keytruda® pembrolizumab injection for intravenous use prescribing information medication guide product website sylatron™ peginterferon alfab for injection for subcutaneous use prescribing information  ml diluent medication guide instructions for use  ml diluent temodar® capsules temozolomide prescribing information patient product information pharmacist information temodar® for injection temozolomide prescribing information patient product information pharmacist information tice® bcg bcg live for intravesical use prescribing information zolinza® vorinostat capsules prescribing information patient product information trademarks appearing on this website are owned licensed to promoted or distributed by merck its subsidiaries or affiliates except as noted merck oncology clinical trials learn more mercks investigational medicines access policy learn more need help paying for your medicines and vaccines learn more report adverse experience to report an adverse experience with a specific merck product please call the merck national service center at  copyright   merck sharp  dohme corp a subsidiary of merck  co inc all rights reserved forwardlooking statement privacy terms of use site map ×close forwardlooking statement forwardlooking statement of merck  co inc kenilworth nj usa this website of merck  co inc kenilworth nj usa the “company” includes “forwardlooking statements” within the meaning of the safe harbor provisions of the united states private securities litigation reform act of  these statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties there can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful if underlying assumptions prove inaccurate or risks or uncertainties materialize actual results may differ materially from those set forth in the forwardlooking statements risks and uncertainties include but are not limited to general industry conditions and competition general economic factors including interest rate and currency exchange rate fluctuations the impact of pharmaceutical industry regulation and healthcare legislation in the united states and internationally global trends toward healthcare cost containment technological advances new products and patents attained by competitors challenges inherent in new product development including obtaining regulatory approval the company’s ability to accurately predict future market conditions manufacturing difficulties or delays financial instability of international economies and sovereign risk dependence on the effectiveness of the company’s patents and other protections for innovative products and the exposure to litigation including patent litigation andor regulatory actions the company undertakes no obligation to publicly update any forwardlooking statement whether as a result of new information future events or otherwise additional factors that could cause results to differ materially from those described in the forwardlooking statements can be found in the company’s  annual report on form k and the company’s other filings with the securities and exchange commission sec available at the sec’s internet site wwwsecgov no duty to update the information contained in this website was current as of the date presented the company assumes no duty to update the information to reflect subsequent developments consequently the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date x worldwide merck canada united states msd merck is known as msd outside the united states and canada clicking on any of the links below will take you to a website intended for those living outside the united states and canada algeria – french argentina – spanish australia – english austria – german belgium – dutch french english brazil – portuguese bulgaria – bulgarian caribbean – english central america – spanish chile – spanish china – simplified chinese colombia – spanish costa rica – spanish croatia – croatian czech republic – czech denmark – danish dominican republic – dominican ecuador – spanish egypt – english estonia – estonian finland – finnish france – french fulford india – english germany – german greece – greek hong kong – chinese english hungary – hungarian india – english indonesia – english ireland – english italy – italian japan – japanese latvia – latvian lithuania – lithuanian malaysia – english mexico – spanish montenegro – serbian netherlands – dutch new zealand – english norway – norwegian peru – spanish philippines – english poland – polish portugal – portuguese puerto rico – spanish english romania – romanian english russia – russian saudi arabia – english serbia – serbian singapore – english slovakia – slovak slovenia – slovene south africa – english south korea – korean spain – spanish sweden – swedish switzerland – english french german taiwan – traditional chinese thailand – thai english turkey – turkish ukraine – ukrainian united kingdom – english venezuela – spanish vietnam – vietnamese close executive officers  nordson corporation nordson corporation global directory  languages nasdaq     home our company about us executive officers executive officers michael f hilton president and chief executive officer mike hilton is president and chief executive officer of nordson corporation since joining nordson in  mr hilton has led the company to record sales and earnings results through a deepened focus on innovative new products emerging markets continuous improvement and strategic acquisitions prior to joining nordson mr hilton spent  years at air products  chemicals inc nyse apd in a variety of roles of increasing responsibility immediately before joining nordson mr hilton served as senior vice president and general manager with specific responsibility for leading air products’ global electronics and performance materials segment he was also responsible for leading the company’s environment health and safety continuous improvement and customer engagement organizations and he served as a member of the company’s corporate executive committee mr hilton serves on the board of directors of ryder system inc nyse r lincoln electric nasdaq leco the board of trustees and the executive council of the manufacturers alliance for productivity and innovation mapi the board of magnet manufacturing advocacy and growth network and the board of friends of breakthrough schools he is also a board member of the nordson corporation foundation and is active in united way and a variety of other charitable endeavors he also is the chair of the ohio federation of independent colleges ofic  statewide campaign mr hilton holds a bs in chemical engineering and an mba from lehigh university   gregory a thaxton senior vice president chief financial officer gregory thaxton greg is corporate senior vice president and chief financial officer of nordson corporation reporting directly to nordson president and ceo michael f hilton in this position mr thaxton oversees the corporate accounting and reporting tax treasury internal audit and investor relations functions prior to being named corporate senior vice president in november  thaxton was previously elected as a nordson corporate vice president in   he became a part of the executive leadership team in february  when he was named corporate controller and chief accounting officer previously mr thaxton served as group controller for the pacific south division and the finishing and coating systems segment as well as the automotive systems and uv curing systems businesses mr thaxton joined nordson in  mr thaxton a certified public accountant holds a bachelors degree in accounting from miami university and a masters degree in business administration from baldwinwallace college  he is a board member of lorain county community college foundation  in addition he is a member of the american institute of certified public accountants aicpa the ohio society of certified public accountants the mapi cfo council and the national investor relations institute niri john j keane senior vice president john keane is senior vice president of nordson corporation with extensive experience within all three of the companys global operating segments  his current duties include the continued integration and optimization of acquired polymer processing product lines within the companys adhesive dispensing systems segment  mr keane joined nordson in  as a project engineer in the converting product line in  he became engineering manager for the packaging and product assembly product lines and in  was appointed to the position of vice president with responsibility for global engineering and marketing in  mr keane was appointed a corporate vice president with responsibility for the finishing and coating systems segment now industrial coating systems in this position he directed worldwide sales marketing engineering and manufacturing functions for the container coating powder coating and liquid finishing businesses in  mr keane was appointed senior vice president with responsibility for the adhesive dispensing systems segment on january   mr keane moved to the advanced technology systems segment where he led nordson’s asymtek march and yestech businesses keane was appointed to lead the entire advanced technology systems segment in december  and continued in that role until  mr keane holds a bachelors degree in mechanical engineering from the massachusetts institute of technology mit and attended the harvard business school’s advanced management program   james e devries vice president global continuous improvement james e devries jim was named a corporate vice president and executive officer of nordson corporation in november   devries serves as nordson’s vice president global continuous improvement reporting directly to nordson president and ceo michael f hilton  mr devries’ current responsibilities include leadership of a global team tasked with setting productivity goals defining key metrics ensuring overall process consistency across the company and leading large enterprise stepchange projects   prior to being named vice president of global continuous improvement in october  mr devries held a variety of operational and engineering positions with increasing responsibilities during his  year career at nordson  as adhesive dispensing systems vice president north america and china engineering  operations he was responsible for two nordson facilities being selected as winners in industryweek magazine’s prestigious best plants competition  nordson’s plants were recognized for excellence in operational improvements agile production systems supplier partnerships customer focus employee empowerment quality systems management practices proactive environmental and safety practices and manufacturing capability   mr devries also previously served as vice president of adhesives dispensing systems’ nonwovens product line and as a systems engineering manager   he began his nordson career in  as an engineer in the company’s industrial coating systems segment  mr devries earned an mba from baldwin wallace college and a bs degree in mechanical engineering from cleveland state university gregory p merk senior vice president gregory p merk greg is a senior vice president of nordson corporation with global responsibility for the packaging nonwovens product assembly and web coating product lines within the adhesive dispensing systems segment   prior to beginning his current role in  mr merk served as vice president of the pacific south division  overseeing nordson’s subsidiary operations and distributor activities in latin america and the asia pacific region from  to  greg served as general manager of nordson do brasillatin south america before being named general manager he was a regional manager in the adhesives systems business in latin america he began his career at nordson in  as a product specialist with the company’s japanese subsidiary nordson kk mr merk holds a bachelor’s degree in finance from the state university of new york   stephen p lovass vice president stephen lovass joined nordson in november of  as corporate vice president with global responsibility for the company’s industrial coating systems business segment which includes the container coating powder coating liquid finishing and automotive assembly product lines in this capacity he directs the sales and marketing product development application engineering manufacturing and product line management functions  prior to joining nordson mr lovass served as president for one of the global sensors and controls businesses at danaher corporation a  billion fortune  diversified science and technology company he holds an mba degree from the university of michigan a bachelor of commerce degree from the university of melbourne australia and the australian equivalent of the certified public accountant designation shelly m peet vice president human resources shelly m peet is vice president human resources of nordson corporation  ms peet joined nordson in september  from trw inc she holds a bachelor’s degree in physics from wittenberg university and bachelor’s and master’s degrees in systems engineering from case western reserve university robert e veillette vice president general counsel and secretary robert e veillette bob is vice president general counsel and secretary of nordson corporation  mr veillette leads the corporate law department which includes both the general and intellectual property law functions  he also serves as corporate secretary mr veillette joined nordson’s legal department in  as an attorney he holds a bachelor’s degree in economics from the university of pittsburgh and a juris doctor degree from the university of akron jeffrey a pembroke vice president jeff pembroke leads the fluid management product lines of nordson’s advanced technology systems segment including nordson efd and nordson medical  mr pembroke joined nordson in  as vice president of sales and marketing for the companys industrial coating  automotive systems segment in  he moved to nordson’s adhesive dispensing systems segment where he served as vice president of sales and marketing with global responsibilities in  he was promoted to president of nordson efd  prior to joining nordson jeff spent  years at general electric starting as a financial analyst before serving in several sales and marketing assignments with increasing responsibility including director of commercial operations for ge advanced materials for the americas  jeff holds a bs degree from the university of new hampshire’s whittemore school of business and economics and is a graduate of ges financial management program fmp     joe stockunas vice president joe stockunas joined nordson in  as group vice president for electronic systems product lines within the advanced technology systems segment he has global responsibility for the nordson asymtek dage dima march and yestech organizations  mr stockunas came to nordson after  years at air products  chemicals inc nyse apd a leading provider of atmospheric gases process and specialty gases performance materials equipment and services to a variety of end markets worldwide most recently he served as air products global business director electronics materials with profit and loss responsibility for a multimillion dollar business supplying high purity gases and chemicals to the global electronics industry mr stockunas holds a bachelor of science degree in metallurgy and materials engineering from lehigh university          in this section our company about us executive officers history philosophy and values nordson business system sustainability corporate headquarters nordson fellowship of distinguished inventors investors corporate governance ethics and responsibility sustainability news room careers community events literature contact us support suppliers resources news on gregory p merk news home advertising board and executive moves energy health care hedge funds m  a private equity technology person gregory p merk ▼ topic all topics ▼ organizations find news about organizations alumni find news on alumni of any org industries find news on a particular market your contacts find news on your contacts sign up for free daily alerts on this feed by pressing sign up you agree to our terms of use privacy policy and the lexisnexis terms  conditions follow change feed gregory p merk gregory p merk sold m worth of shares in nordson corp in august  september    •  relsci data update related news feeds nordson corp alumni of state university of new york gregory p merk email linkedin facebook google tweet reddit permalink want to see the full history of news or view news on a particular date upgrade to relsci professional now start my free trial ➤ industry select a topic keyword go  ➤ find an organization select a topic keyword go  ➤ find a person select a topic keyword go  ➤ name of a school or name of an organization select a topic keyword go  ➤ thank you you are now subscribedplease wait for the page to refresh you are now subscribed to this feed you have unsubscribed to this feed thank you you can now subscribe to more relsci news feeds to subscribe to more than one feed please enter a password please confirm your password go  ➤ youve found a premium relsci pro feature follow news on your contacts upgrade to relsci pro now to easily sync your contacts and stay in the know on the news about the people important to you start my free trial ➤ still not convinced check out our full listing of features here not now youve found a premium relsci pro feature search news on keywords curate your news even further with the ability to filter feeds based on specific keywords mentioned in the articles start my free trial ➤ still not convinced check out our full listing of features here not now industries find news on a particular market people find news about people organizations find news about organizations alumni find news on alumni of any org your contacts find news on your contacts free daily alerts sign up for free daily alerts on this feed sign up ➤ by pressing sign up you agree to our terms of use privacy policy and the lexisnexis terms  conditions already have an account click here to login are you a relsci pro subscriber login to relsci pro  ➤ not a pro subscriber log in here to manage your alerts keep me signed in login  ➤ forgot your password i have read the lexisnexis terms  conditions sign me up  ➤ insider trading  merk gregory p  form  sec filings home  archives  products  about  contact  faq  new user sign up  sign in form  filings insider buys significant buys penny stocksinsider buying insider sales insider buy sell ratios stock options insider tradingstock screener insider tradinggraph view insider watch sec filings insider trading  merk gregory p select time period  month  months  months  months  year  years  years  years all data       google     yahoo send this page to   blog    digg    reddit    facebook    stumble    delicious enter stock ticker symbol or cik cik lookup search by company or insider name insiders might sell their shares for any number of reasons but they buy them for only one they think the price will rise  peter lynch  what is insider trading email a friend  historical filings delayed by  months new user sign up for real time data existing user sign in common stock purchase or sale transactiondate reporteddate company symbol insiderrelationship sharestraded averageprice totalamount sharesowned filing sale  pm nordson corp ndsn merk gregory psenior vice president    indirectdirect view sale  pm nordson corp ndsn merk gregory psenior vice president    indirectdirect view sale  pm nordson corp ndsn merk gregory psenior vice president    indirectdirect view sale  am nordson corp ndsn merk gregory psenior vice president    indirectdirect view stock options exercise award grant conversion transactiondate reporteddate exercisableexpiration company symnbol insiderrelationship sharestraded conversionprice sharesowned filing tax withholding  pm nana nordson corp ndsn merk gregory psenior vice president   direct view option award  pm nana nordson corp ndsn merk gregory psenior vice president   direct view tax withholding  pm nana nordson corp ndsn merk gregory psenior vice president   direct view tax withholding  pm nana nordson corp ndsn merk gregory psenior vice president   direct view tax withholding  pm nana nordson corp ndsn merk gregory psenior vice president   direct view option award  pm nana nordson corp ndsn merk gregory psenior vice president   direct view option award  pm nana nordson corp ndsn merk gregory psenior vice president   direct view option award  pm na nordson corp ndsn merk gregory psenior vice president   direct view exercise  pm nana nordson corp ndsn merk gregory psenior vice president   direct view exercise  pm na nordson corp ndsn merk gregory psenior vice president   direct view exercise  pm nana nordson corp ndsn merk gregory psenior vice president   direct view exercise  pm nana nordson corp ndsn merk gregory psenior vice president   direct view exercise  pm nana nordson corp ndsn merk gregory psenior vice president   direct view exercise  pm na nordson corp ndsn merk gregory psenior vice president   direct view exercise  pm na nordson corp ndsn merk gregory psenior vice president   direct view exercise  pm na nordson corp ndsn merk gregory psenior vice president   direct view exercise  pm nana nordson corp ndsn merk gregory psenior vice president   direct view exercise  pm na nordson corp ndsn merk gregory psenior vice president   direct view tax withholding  pm nana nordson corp ndsn merk gregory psenior vice president   direct view tax withholding  pm nana nordson corp ndsn merk gregory psenior vice president   direct view option award  pm nana nordson corp ndsn merk gregory psenior vice president   direct view tax withholding  pm nana nordson corp ndsn merk gregory psenior vice president   direct view option award  pm nana nordson corp ndsn merk gregory psenior vice president   direct view option award  pm nana nordson corp ndsn merk gregory psenior vice president   direct view tax withholding  pm nana nordson corp ndsn merk gregory psenior vice president   direct view option award  pm na nordson corp ndsn merk gregory psenior vice president   direct view exercise  am nana nordson corp ndsn merk gregory psenior vice president   direct view other  am nana nordson corp ndsn merk gregory psenior vice president   direct view exercise  am  nordson corp ndsn merk gregory psenior vice president   direct view tax withholding  am nana nordson corp ndsn merk gregory psenior vice president   direct view   secformcom all rights reserved archives        wed  jul    sec is the us securities and exchange commission edgar is a trademark of the sec secformcom is not affiliated with or approved by the us securities and exchange commission sec terms of use  privacy statement  gregory p merk  executive bio compensation history and contacts  equilar atlas   log in  sign up x   as featured in gregory p merk senior vice president at nordson corporation view full profile are you gregory p merk claim your profile   sign up for equilar atlas and view gregory p merks full profile with equilar atlas you can identify corporate executives in gregory p merks network and community follow changes in gregory p merks employment and moneyinmotion connect with gregory p merk through your network of contacts gregory p merks executive work history current senior vice president nordson corporation past to view gregory p merks complete executive work history sign up now age      gregory p merks biography senior vice president  vice president  source nordson corporation on    sign up for equilar atlas and view gregory p merks full profile by accessing equilar atlas you can view bios network salary and wealth events of industryleading executives like gregory p merk more specifically youll be able to identify corporate executives in gregory p merks network and community follow changes in gregory p merks employment and moneyinmotion connect with gregory p merk through your network of conections view full profile   search for over  executive profiles bio example gregory p merk gregory p merks connections  sign up now to view gregory p merks  connections » michael f hilton dir president and chief executive officer nordson corporation stephen r hardis former chairman and chief executive eaton corporation plc robert e veillette vice president general counsel and secretary nordson corporation edward p campbell former chairman of the board and chief executive officer nordson corporation mark g gacka former vice president nordson corporation arthur l george board member nordson corporation peter g lambert former senior vice president nordson corporation douglas c bloomfield former vice president nordson corporation john j keane senior vice president nordson corporation peter s hellman board member baxter international inc popular profiles sign up now to view more executive profiles » thomas j lynch executive chairman te connectivity ltd john j kita evp and cfo a o smith elon r musk ceo and chairman tesla david j oconnor president and ceo the madison square garden company carl g annessa evp and coo hornbeck offshore services inc × claim your profile coming soon interested in updating your biography and work history were working on making it happen well email you when this feature is available please enter valid email address done thank you for your interest ok browse executive profiles  a  b  c  d  e  f  g  h  i  j  k  l  m  n  o  p  q  r  s  t  u  v  w  x  y  z equilar homepage equilar atlas equilar insight equilar boardedge equilar engage research services knowledge network about us login �  equilar all rights reserved privacy policy  marshall street redwood city ca   phone    fax   gregory merk nordson corp profile  biography  bloomberg feedback gregory merk senior vice president nordson corp career history senior vice president nordson corp present vppacific south  japan nordson corp  president nordson kk unknown general manager nordson corp  product specialist nordson kk unknown various positions nordson corp former show more website wwwnordsoncom corporate information address  clemens road westlake oh  united states phone  fax  web url wwwnordsoncom from the web personal information education state university of new york bachelors degree memberships board memberships nordson kk board member present sponsored financial commentaries more from the web home news top headlines most popular exclusive law entrepreneurs leaders economy environment science sports markets magazine pursuits magazine bloomberg visual data bloomberg best and worst for comments or complaints about news coverage click here regions us china europe asia uk  ireland australia  new zealand canada india  pakistan japan africa eastern europe latin america middle east markets commodities currencies bonds stocks energy markets municipal bonds emerging markets funds islamic finance industries energy technology real estate finance health care transportation insurance retail media manufacturing quick market data stocks stock futures world indexes americas europe middle east  africa asiapacific gainers  losers earnings calendar industry leaders currencies americas europe middle east  africa asiapacific foreign exchange cross rates fx fixings currency converter forex trading videos commodities energy prices metals prices agricultural prices rates  bonds us treasuries uk gilts germany bunds japan bonds australia bonds bloomberg bond indexes corporate bonds consumer rates economic calendar watchlist european debt crisis symbol search the market now personal finance top headlines saving  investing real estate retirement planning financial advisers taxes blog ventured  gained real cost of money gallery calculators watchlist portfolio tracker tech top headlines social media mobile  wireless web enterprise tech tv games  movies apple tech deals global tech slideshows videos us politics sustainability top headlines energy corporate sustainability policy natural resources health  population slideshows videos blog the grid luxury top headlines autos billionaires living property travel well spent loot blog pursuits magazine videos tv live tv channel finder personalities apple tv ipad app schedule us asia europe shows surveillance market makers lunch money street smart bloomberg west game changers video must see latest live tv shows playlist radio live radio shows schedule personalities podcasts bloomberg brief featured podcasts and new shows bloomberg view masters in business first word surveillance bloomberg advantage in the loop bloomberg law taking stock bloomberg best more podcasts blogs global tech the grid loot the market now political capital tech deals ventured and gained opinion my saved registration sign in bloombergcom businessweekcom company about blog careers diversity  inclusion news mission philanthropy  engagement press room procurement sustainability products financial products bloomberg professional service bloomberg anywhere bloomberg tradebook bloomberg briefs bloomberg indexes bloomberg sef service center customer support enterprise products enterprise solutions trading solutions industry products bloomberg bna bloomberg government bloomberg law bloomberg link bloomberg new energy finance bloomberg sports content licensing bloomberg anywhere mobile apps bloomberg visual data gregory p merk nordson corporation svp adhesive dispensing systems  redbooks brands marketers agencies search less sell more    sign in get a free trial    contact us   gregory p merk svp adhesive dispensing systems nordson corporation email realtime sales trigger feed  generated by redbooks machine learning and natural language processing technology tracking  news sources to aggregate all new executives jobrole changes and news on decision makers brands and agencies in the mediamarketing industry this sales feed is for gregory p merk at nordson corporation gregory p merk works as svp adhesive dispensing systems  nordson corporation is a leader in machinery  supplies  redbooks tracks personnel changes for advertisers spending over  million annually for more leads or mediamarketing prospecting automation start a free trial now recent related news  nordson corporation nasdaqndsn sees unusual trading volume in its shares trading volume for nordson corporation was k by the end of trading on wednesday volume was up  over the stocks average daily volume short traders are feeling a little more bullish on shares of the company recently if you look at the decrease in short interest the firm experienced a fall in short interest between june   and may   of  short interest fell from  to  over that period the days to cover decreased to  and the percentage of shorted shares was  on may   people in this article gregory p merk  nordson corporation nasdaqndsn trading up – shorts down  short traders are more bullish lately as indicated by the fall in short interest the company realized a fall in short interest from june   to may   of  short shares decreased from  to  over that timeframe days to cover decreased  to  and the percentage of shorted shares was  on may  here is the rundown on market activity for nordson corporation nasdaqndsn sr vp gregory a thaxton disclosed the sale of  shares the shares were purchased at an average price of   people in this article gregory p merk learn more about gregory p merk and  key contacts   create targeted lead lists   gain insider knowledge with advanced machine  learning   realtime verified contact info enter work email please enter email address please enter valid email address learn more about gregory p merk and  key contacts first name  please enter first name last name  please enter last name company name  please enter company name email  phone  please enter phone number please enter  digits number what industry are you in    please select one the categories below please enter value for the industry  media sales  production  adtechmartech  sponsorship sales   agency new business   other what is your role    please select one the categories below please enter value for the role   csuite   vpmanager   sales rep   other thank you for registering for a free redbookscom trial we are processing your request and will be in touch shortly to get you started for immediate assistance please call us at   or email us at inforedbookscom home learn more free trial features ad think events thought leadership events top advertiser directory top agency directory add your agency update your agency agency showcase advertising associations creative spotlight services and suppliers about us blog contact us jobs terms  conditions privacy policy customer support   connect with us copyright   red books llc all rights reserved view all merck products are you a health care professional the information on this site is intended for health care professionals in the united states its territories and puerto rico and is not intended for the general publici am a health care professionali am not a health care professional       register log in dr del monte products health care topics diabetes medication adherence oncology topics in health care series live webcasts services request product samples coupons and vouchers order vaccines professional information requests get support contact us faqs professional information requests explore merck log out           breadcrumb  view merck products this is a select list of merck products the product web sites presented here are intended for health care professionals in the united states its territories and puerto rico only to learn about vaccines from merck please visit merckvaccinescom a b c d e f g h i j k l m n o p q r s t u v w x y z asmanex® hfa mometasone furoate inhalation aerosol prescribing information patient information view product site asmanex® twisthaler® mometasone furoate inhalation powder prescribing information patient information view product site belsomra® suvorexant tablets civ prescribing information medication guide view product site bridion® sugammadex injection prescribing information view product site cubicin® daptomycin for injection for intravenous use prescribing information view product site dificid® fidaxomicin tablets prescribing information view product site dulera® mometasone furoate and formoterol fumarate dihydrate inhalation aerosol before prescribing dulera please read the prescribing information including the boxed warning about asthmarelated death prescribing information medication guide view product site emend® aprepitant capsules prescribing information patient information instructions for use view product site emend® fosaprepitant dimeglumine for injection prescribing information  mg edta formulation prescribing information  mg edta formulation patient information view product site entereg® alvimopan capsules before prescribing entereg please read the prescribing information including the boxed warning about potential risk of myocardial infarction with longterm use prescribing information view product site follistim® aq cartridge follitropin beta injection for subcutaneous use prescribing information patient information view product site foradil® aerolizer® formoterol fumarate inhalation powder  mcg before prescribing foradil aerolizer please read the prescribing information including the boxed warning about asthmarelated death prescribing information medication guide ganirelix acetate injection prescribing information view product site implanon® etonogestrel implant for subdermal use prescribing information patient information integrilin® eptifibatide injection for intravenous use prescribing information invanz®ertapenem for injection for intravenous iv or intramuscular im use prescribing information isentress®raltegravir filmcoated tablets prescribing information patient information instructions for use view product site isentress® hd raltegravir filmcoated tablets  mg prescribing information patient information instructions for use view product site janumet®sitagliptin and metformin hci tablets before prescribing janumet please read the prescribing information including the boxed warning about lactic acidosis prescribing information medication guide view product site janumet® xrsitagliptin and metformin hcl extendedrelease tablets before prescribing janumet xr please read the prescribing information including the boxed warning about lactic acidosis prescribing information medication guide view product site januvia®sitagliptin tablets prescribing information medication guide view product site nexplanon®etonogestrel implant radiopaquesubdermal use only prescribing information patient information view product site noxafil®posaconazole oral suspension delayedrelease tablets and injection prescribing information patient product information view product site nuvaring®etonogestrelethinyl estradiol vaginal ring before prescribing nuvaring please read the prescribing information including the boxed warning about the increased risk of serious cardiovascular side effects especially in women who smoke prescribing information patient information pregnyl®chorionic gonadotropin for injection usp prescribing information view product site proventil® hfa albuterol sulfate inhalation aerosol prescribing information patient information renflexistminfliximababda for injection for intravenous use before prescribing renflexis please read the prescribing information including the boxed warning about serious infections and malignancies the medication guide also is available prescribing information medication guide view product site sivextro® tedizolid phosphate injection for intravenous use and tablets prescribing information view product site vytorin®ezetimibe and simvastatin tablets prescribing information patient information zepatier®elbasvir and grazoprevir tablets before prescribing zepatier please read the prescribing information including the boxed warning about the risk of hepatitis b virus hbv reactivation in patients with hbv coinfection prescribing information patient information view product site zerbaxatm ceftolozane and tazobactam for injection prescribing information view product site zetia®ezetimibe tablets prescribing information patient information zinplavatm bezlotoxumab injection  mgml prescribing information patient information view product site terms of use privacy policy this site is intended for health care professionals in the united states its territories and puerto rico copyright   merck sharp  dohme corp a subsidiary of merck  co inc all rights reserved  merck  co inc usa please orient your device to the portrait position to return to the site close  you are about to leave merck connecttm you are now leaving merck connect for another merck web site to return to the page you were viewing click close to continue click ok ok  ﻿ merckcom  homepage worldwide  contact us contact us faq navigation about us × about us about us corporate responsibility reimbursement support and patient assistance programs leadership – board of directors – executive committee our work our work in antimicrobial resistance our work in hepatitis c our work in diabetes our work in oncology our work in hiv our work in vaccines how we operate – code of conduct our values and standards our values and standards for external business partners – compliance – privacy – transparency and privacy – internet privacy policy – cookie privacy commitment – cross border policy – employment privacy  data protection – diversity – employee diversity – supplier diversity programs and partnerships what we buy definitions register potential supplier supplier diversity views and positions – access and affordability – access to investigational medicines – innovation – quality and safety – sales and marketing – responsible public policy and advocacy public policy position statements trade association memberships our history company fact sheet our people featured stories our legacy  and future  in american manufacturing mercks it organization expands into austin texas mectizan donation is one for the record books journey for control a point of view by dr bao lam fighting some of the worlds toughest bacterial infections meet dan cua it takes a village type  diabetes a focus on ac may is for mothers pushing to outpace superbugs merck announces enhancements to family leave time classical hodgkin lymphoma facing cancer in young adulthood world sleep day bekindalwaysnoah the merckregenstrief collaboration why drug discovery is the foundation of merck’s future how chronic hepatitis c is impacting our veterans meet gokul swaminathan merck honors research microbiologist h boyd woodruff phd merck uses amazon web services to develop voiceenabled solutions cancer needs cures still merck be well challenge  — bringing the outside in a point of view by adam schechter president of global human health at merck your cancer game plan merck foundation grant helps expand project echo merck’s commitment to prevention and care for ncds meet jay schiller merck research laboratories expands into south san francisco test talk take action bridging the gap in diabetes care world diabetes day  meet harriet johnson merck employees surpass goal of  volunteer hours merck for mothers  pep talk meet commander adam scott meet noreen rizvi ebola outbreak a point of view by dr roger dansey a point of view by dr gregory lubiniecki merck’s susan shiff selected faces of the future merck research laboratories honored living with breast cancer health literacy a point of view by julie gerberding md mph meet paige cramer merck releases  corporate responsibility report how merck animal health helped to curb a new strain of civ women in science  merck fellowship for global health meet daria hazuda a point of view by dr jonathan cheng understanding head and neck cancer hpv awareness meet arnaub chatterjee fasting and diabetes understanding diabetes living with type  diabetes its personal series collaborating to cure meet mike thien roy vagelos honored by american heart association changing the statistics charting a new course in cancer care new approaches to fighting cancer melanoma never walk alone be safe in the sun americas diabetes challenge world immunization week merck for mothers at the women in the world summit vaccines our history our legacy the impact of cancer merck’s commitment to hepatitis c hepatitis c a silent disease and growing concern using water wisely meet george w merck heart disease guided by research inspired by hope why animal health matters merck turns  cervical health awareness month rallying to meet the need william campbell wins nobel prize meet christopher kistler diversity and inclusion good for business understanding alzheimer’s disease living with hiv meet jason cheung hepatitis c a medical — and social — diagnosis the fight against hepatitis c saluting those who serve lung cancer challenges and reasons for hope real innovation world diabetes day lung cancer refugee and migrant relief efforts what is c difficile beyond tired so are they meet alexander buitrago santanilla ken frazier receives lifetime achievement award merck employees walk to end alzheimer’s ken frazier at the clinton global initiative helping to advance a new set of un global goals merck fellowship for global health  corporate responsibility report new therapies to attack infections the race against resistance identifying the next generation of antibacterial therapies the fight against antimicrobial resistance mectizan donation program meet paul reichert merck for mothers at tedwomen meet spencer dreher merck and hivaids fasting and diabetes mercks rule the real talk campaign meet daisy richardson art for all msd in japan bringing back the beach a commitment to diabetes research a silent disease and growing concern meet tim cernak melanoma  never walk alone be safe in the sun may is for mothers bone health awareness americas diabetes challenge pushing to outpace superbugs the evolution of cancer research parasites and your pets meet ayesha sitlani every woman every child event everyday heroes new approaches to fighting cancer insomnia advancing oncology research through clinical trials bridging the gap in diabetes care closing the circle on rabies desafiando la diabetes understanding diabetes helping empower women living with hiv diabetes and travel vaccines our history our legacy the impact of cancer a point of view by eric rubin md making a difference inventing for life × inventing for life inventing for life products × products products product list az vaccines  prescribing information prescription products  prescribing information oncology products  prescribing information animal health product patents authorized distributors vaccine contracted distributors research × research research our people our culture – the mrl postdoctoral research fellow program our rd process what were working on pipeline clinical trials invent with us discover where our research happens licensing × licensing business development  licensing incyte moderna ngm biopharmaceuticals bdl contacts news  events newsroom × newsroom newsroom news releases – prescription medicine news – consumer care news – vaccine news – research  development news – corporate news – financial news – corporate responsibility news – animal health news information centers – diabetes – ebola – hepatitis c – oncology company statements media center company snapshot social media careers × careers careers apply now what’s possible my career journey merck anna dickstein my career journey merck fran murphy my career journey merck paige cramer why merck – diversity at merck – from service to science – prepared for launch – compensation and benefits how will you invent the future my career journey merck frank clyburn canada msd worldwide investors × investors investors product pipeline news events  presentations stock info – stock quote  chart – historical price lookup – investment calculator – dividend history – stock splits – analyst coverage financials – quarterly reports – annual reports  proxy – sec filings governance investor resources – faqs – stockholder services – corporate responsibility – information request – sign up for email alerts – other – contact us menu menu previous next latest news see all latest news social merck connect with us other merck sites merck for mothers merckhelps msdcom clinical trials corporate responsibility merck corporate responsibility website transparency disclosures california supply chains act merck animal health merck manuals merckengage merck connect reimbursement support and patient assistance programs univadis a service of merck subsidiary aptus health copyright   merck sharp  dohme corp a subsidiary of merck  co inc all rights reserved forwardlooking statement privacy terms of use site map ×close forwardlooking statement forwardlooking statement of merck  co inc kenilworth nj usa this website of merck  co inc kenilworth nj usa the “company” includes “forwardlooking statements” within the meaning of the safe harbor provisions of the united states private securities litigation reform act of  these statements are based upon the current beliefs and expectations of the company’s management and are subject to significant risks and uncertainties there can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful if underlying assumptions prove inaccurate or risks or uncertainties materialize actual results may differ materially from those set forth in the forwardlooking statements risks and uncertainties include but are not limited to general industry conditions and competition general economic factors including interest rate and currency exchange rate fluctuations the impact of pharmaceutical industry regulation and healthcare legislation in the united states and internationally global trends toward healthcare cost containment technological advances new products and patents attained by competitors challenges inherent in new product development including obtaining regulatory approval the company’s ability to accurately predict future market conditions manufacturing difficulties or delays financial instability of international economies and sovereign risk dependence on the effectiveness of the company’s patents and other protections for innovative products and the exposure to litigation including patent litigation andor regulatory actions the company undertakes no obligation to publicly update any forwardlooking statement whether as a result of new information future events or otherwise additional factors that could cause results to differ materially from those described in the forwardlooking statements can be found in the company’s  annual report on form k and the company’s other filings with the securities and exchange commission sec available at the sec’s internet site wwwsecgov no duty to update the information contained in this website was current as of the date presented the company assumes no duty to update the information to reflect subsequent developments consequently the company will not update the information contained in the website and investors should not rely upon the information as current or accurate after the presentation date